Note: Ingredients listed on restricted chemical lists
EC/CAS
9004-34-6
Name of the chemical
cellulose
Concentration
50.0-60.0 19.0-21.0
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
<2.0
General Information
Revision date
2018-05-25
Product name
TAFENOQUINE TABLETS
Product Synonyms
TAFENOQUINE TABLETS 100mg * TAFENOQUINE TABLETS 150mg * TAFENOQUINE
Icons in SDS
Company Information
company name
GlaxoSmithKline Australia Phamaceuticals and Vaccines
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
Section 2
2.1 Classification of the substance or mixture
Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device. Label elements, including precautionary statements Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
Other hazards which do not result in classification
Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
